Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 314 of 5804
-
New scope surgery may improve outcomes for babies with meningitis complications
Disease control Not yet recruitingGlobally, approximately 750,000 cases of infantile meningitis occur annually\[1\]. Clinical data show infantile postmeningitis subdural fluid collection (IPSFC) is the most common complication of infantile bacterial meningitis (IBM), with a progression rate of 30-60% (39% in stan…
Sponsor: Shengjing Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New Three-Drug cocktail aims to fight tough lung cancer
Disease control Not yet recruitingThe study consists of two parts: Part I is a randomized, double-blind, multicenter, parallel-controlled phase II clinical study to evaluate the efficacy and safety of HLX07 in combination with serplulimab and chemotherapy versus placebo in combination with serplulimab and chemot…
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New antibody drug aims to ease endometriosis pain in major trial
Symptom relief Not yet recruitingA phase 3 study to evaluate the efficacy and safety of HMI-115 in women with moderate to severe endometriosis-associated pain over a 24-week treatment period and a 28-week extension
Phase: PHASE3 • Sponsor: Hope Medicine (Nanjing) Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New stroke drug combo aims to boost recovery in Late-Treated patients
Disease control Not yet recruitingThis is a multicenter, randomized, open-label, blinded-endpoint clinical trial designed to evaluate the efficacy and safety of early administration of eptifibatide following intravenous thrombolysis in patients with acute ischemic stroke who present 4.5 to 24 hours after symptom …
Phase: PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
AI helps surgeons see brain tumors better during surgery
Diagnosis Not yet recruitingIntraoperative ultrasound is a versatile, low-cost imaging tool that has been shown to improve safety and efficacy in brain tumor surgery. However, its widespread adoption remains limited due to operator dependency, the complexity of image interpretation, the presence of artifact…
Phase: PHASE3 • Sponsor: Hospital del Rio Hortega • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Double attack: surgery plus laser zaps deadly brain tumors
Disease control Not yet recruitingButterfly glioblastomas (bGBM), defined as tumours crossing the midline to involve hemispheres bilaterally, have a dismal prognosis with a median survival of 3.3-6 months and only 9% of patients with bGBM survive 2-years. These figures put bGBM in the worst end of the spectrum of…
Phase: NA • Sponsor: King's College Hospital NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could induced hypothermia save brains after stubborn seizures?
Disease control Not yet recruitingThe HYBERNATUS-II study is a phase-III, open-label, randomized controlled trial in patients with convulsive refractory SE receiving mechanical ventilation. Patients are allocated at random to either early targeted hypothermia for 24 hours or targeted normothermia at the acute pha…
Phase: PHASE3 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Engineered immune cells take aim at multiple sclerosis and myasthenia gravis
Disease control Not yet recruitingThis is an open label, single-site, dose-escalation study in up to 15 participants with relapsed or refractory Neurological Autoimmune Diseases. This study aims to evaluate the safety and efficacy of the treatment with universal CD19/BCMA CAR T-cells(QT-019C).
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
AI model aims to predict surgery risks for stomach cancer patients
Diagnosis Recruiting nowGastric cancer is a leading cause of cancer-related mortality, and radical surgery remains the primary treatment. However, postoperative complications are common and can significantly impact patient recovery and quality of life. Currently, doctors lack precise tools to accurately…
Sponsor: Qun Zhao • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
Heart scar on MRI may decide who gets a lifesaving shock device
Disease control Not yet recruitingResearch questions: The value of primary prevention implantable cardioverter-defibrillator implantation (ICD) therapy in patients with non-ischemic cardiomyopathy (NICM) is under debate. Improved risk stratification is needed to select patients at highest risk. Hypotheses: 1. In…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New screening strategy aims to cut preterm births by half
Prevention Not yet recruitingThis cluster non-randomized controlled trial aims to evaluate the effectiveness and feasibility of a risk score-guided targeted cervical length screening strategy for the prevention of spontaneous preterm birth in routine community-based prenatal care. Pregnant women are first as…
Phase: NA • Sponsor: Ningbo University • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Could anakinra save brain tissue after a stroke? new trial aims to find out
Disease control Not yet recruitingThe investigators initiated a multicenter, prospective, randomized, open label, blinded-endpoint (PROBE) controlled trial to explore the safety and efficacy of different dose of Anakinra compared to standard medical care for patients with acute ischemic stroke who have achieved s…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Gene therapy hope for sickle cell: tiny trial tests One-Time fix
Disease control Not yet recruitingIt is a single-arm, single-center, open-label, single-dose study. A total of three subjects with severe sickle cell disease (SCD), aged 12-50 years (inclusive), are planned to receive cell infusion. After successful hematopoietic stem cell engraftment is achieved in the first sub…
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New stitch procedure could help obese patients shed pounds without surgery
Disease control Not yet recruitingEGO-Trial is the first multicenter study in France which aims to evaluate the efficacy of Endoscopic Sleeve Gastroplasty (ESG) in patients with obesity. This project fills a critical national gap by providing real-world, multicentric data from diverse French healthcare settings, …
Sponsor: IHU Strasbourg • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New combo procedure aims to fix heart rhythm and prevent stroke in one go
Disease control Not yet recruitingA multicenter, prospective registry of concomitant Farapulse (Boston scientific) based PVI and Watchman Flx device (Boston scientific) based LAAC procedures was planned in order to assess the acute and mid-time safety, efficacy and efficiency of this approach (COCONUT II study). …
Phase: NA • Sponsor: Asklepios proresearch • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Glow-in-the-Dark dye could help surgeons spot hidden prostate cancer
Diagnosis Not yet recruitingThis study is a single-center, single-arm, open-label exploratory study to evaluate the safety and efficacy of fluorescent imaging combined with a robotic surgical control system for robot-assisted radical prostatectomy.
Phase: PHASE2 • Sponsor: Zhu Yinjie • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
AI could solve thyroid nodule mystery: new study aims to predict cancer risk
Diagnosis Recruiting nowThe prospective study aim to develop a multimodal deep learning model that integrates ultrasound images and cytological whole-slide images for more accurate malignant risk prediction of Bethesda III thyroid nodules.
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New drug combo aims to wipe out lung cancer before surgery
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of JSKN016 combined with toripalimab and carboplatin as a neoadjuvant treatment regimen in patients with resectable stage II-III NSCLC.
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could tailored tamoxifen doses keep more breast cancer patients on treatment?
Disease control Not yet recruitingIn Sweden, approximately 7000 women are diagnosed with hormone-sensitive breast cancer annually. According to international and national guidelines, most of these women are recommended anti-hormonal therapy for five to ten years to improve prognosis. Tamoxifen, one of the most wi…
Phase: PHASE3 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a simple vitamin boost plaque stability and cut stroke risk?
Disease control Recruiting nowThis is a prospective, exploratory, cohort clinical study aiming to further investigate the direct impact of folic acid on the stability of carotid atherosclerotic plaques, building upon substantial clinical evidence confirming that folic acid supplementation reduces the risk of …
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC